Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"
Meldola, Emilia-Romagna, Italyirst.emr.it ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
IRST has strong clinical trial activity and leads several pragmatic and translational studies, including large multicenter trials in acute myeloid leukemia (IMPACT-AML), functional precision therapies for pancreatic cancer, breast cancer screening initiatives, CAR-T cell immunotherapy innovations, and outcome research involving real-world data. Recent clinical results include real-world evidence development in refractory AML, advanced breast cancer screening strategies, and multiple publications in novel therapeutic modalities.
- Therapeutic areas
- OncologyHematology
- Modalities
- Small moleculeMonoclonal antibodyImmunotherapyCell therapyCAR-T cell therapyRadiopharmaceuticalRecombinant proteinBiomarkersAdvanced Therapy Medicinal Product (ATMP)
- Industry
- Academic Hospital/University/Research
02
Partnerships
AUSL RomagnaUniversity of BolognaIstituto Oncologico Romagnolo (IOR)European Commission (Horizon Europe projects)TriNetX (data platform for RWE)Alliance Against Cancer (ACC network)BBMRI-ERIC (Biobank)
Beyond the preview
Go deeper on Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori".
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori".